Associate Dean Xiang-Qun (Sean) Xie, MD, PhD, was appointed a member of the U.S. Food and Drug Administration Science Board serving a term to 2018. Xie was appointed by Jill Hartzler Warner, J.D., Associate Commissioner of Department of Health and Human Services, Food and Drug Administration.
As a member of the FDA’s highest advisory board, Xie will provide advice to the commissioner and other appropriate officials on specific complex scientific and technical issues important to FDA and its mission, including emerging issues within the scientific community. Additionally, the Science Board will provide advice that supports the Agency in keeping pace with technical and scientific developments, including in regulatory science; and input into the Agency’s research agenda; and on upgrading its scientific and research facilities and training opportunities. It will also provide, where requested, expert review of Agency sponsored intramural and extramural scientific research programs.
Xie is associate dean of research innovation and professor of pharmaceutical sciences at PittPharmacy. Xie is the director of NIH National Center of Excellence for Computational Drug Abuse Research.
